Transdermal Drug Delivery Market: Jsbmarketresearch

GLOBAL TRANSDERMAL DRUG DELIVERY MARKET TO 2020 Strategic Analysis

Released On 16th October 2015

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables & figures over 280 pages.

This report is presented as follows:

• By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER, NOVARTIS, NOVEN, LAVIPHARM, PROSTRACKEN, NITTO DENTO)

• By Geography (Global, USA)

• By Parent Market (Drug Delivery Systems, Advanced Drug Delivery Systems)

• By Sub-market (Generics, Women’s Health, Analgesics, Neuropathic Pain)

A wealth of financial data & business strategy information is provided including:

• Up-to-date company financials, sales & revenue figures

• Revenue and market forecasts

• Business model strategies for drug delivery, pharmaceutical and biotechnology companies

• Comprehensive account of company products, financials & portfolios

SWOT, Economic & Regulatory Environment specifics include:

• Key strengths, weaknesses and threats influencing leading player position within the market

• Technologies driving the market (e.g., chemical enhancers, microneedles)

• Top fastest growing market segments and emerging opportunities

• Top pharmaceutical companies within the market

• Comprehensive product portfolios, R&D activity and pipeline products

• M&A activity and future strategies of top companies

• High demand and unmet need enhances the market

• Challenges of the transdermal drug delivery market

Who should read this report?

• Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine

• Industry professionals and business strategists will discover key information to propel their policies

• Investors will gain inside information to dominant players in the industry and future forecasts

• Scientists will get a business...